1322062-76-9: Lacosamide EP Impurity D (HCl salt)

Also known as Lacosamide N-Desacetyl Impurity (HCl salt), it is one impurity present in Lacosamide, Lacosamide may be selective for inhibiting depolarized neurons rather than neurons with normal resting potentials. Pain and nociceptor hyperexcitability are associated with neural membrane depolarization. Lacosamide binds to collapsin response mediator protein-2, a phosphoprotein that is expressed primarily in the nervous system and is involved in neuronal differentiation and control of axonal outgrowth. The role of CRMP-2 of binding in seizure control, which is used to treat partial onset seizures.

Additional information on CAS 1322062-76-9

Catalogue No.

VE009203

CAS No.

1322062-76-9

Molecular Formula

C11H17ClN2O2

Molecular Weight

244.72 g/mol

Parent drug

Lacosamide

IUPAC Name

(2E)-2-amino-N-benzyl-3-methoxypropanamide hydrochloride

Synonyms

Lacosamide N-Desacetyl Impurity (HCl salt)

References

Abou-Khalil, B. W. (2009). Lacosamide: What Can be Expected from the Next New Antiepileptic Drug? Epilepsy Currents, 9(5), 133–134. https://doi.org/10.1111/j.1535-7511.2009.01317.x

Status

In-stock

[rfq_list]

Login first to add product to RFQ List

Request a quote

1322062-76-9: Lacosamide EP Impurity D (HCl salt)

1322062-76-9: Lacosamide EP Impurity D (HCl salt)
Catalogue No.

VE009203

CAS No.

1322062-76-9

Molecular Formula

C11H17ClN2O2

Molecular Weight

244.72 g/mol

Parent drug

Lacosamide

IUPAC Name

(2E)-2-amino-N-benzyl-3-methoxypropanamide hydrochloride

Synonyms

Lacosamide N-Desacetyl Impurity (HCl salt)

References

Abou-Khalil, B. W. (2009). Lacosamide: What Can be Expected from the Next New Antiepileptic Drug? Epilepsy Currents, 9(5), 133–134. https://doi.org/10.1111/j.1535-7511.2009.01317.x

Status

In-stock

ListName

Lacosamide EP Impurity D (HCl salt)

Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url
 
Hidden